Boehringer Ingelheim Company History Timeline

(753 Jobs)
2008

Starting in 2008, people began filing lawsuits claiming that Spiriva could cause fatal heart problems such as heart attacks, strokes and cardiovascular death.

In 2008, the FDA issued a safety communication warning of the increased risk.

2012

But by the end of 2012, Pradaxa was linked to more than 500 deaths involving hemorrhaging and uncontrolled bleeding.

2013

United States Food and Drug Administration. (2013, March 14). FDA Drug Safety Communication: FDA investigating reports of possible increased risk of pancreatitis and pre-cancerous findings of the pancreas from incretin mimetic drugs for type 2 diabetes.

In 2013, the FDA said that studies suggested drugs in the incretin mimetic class, including Tradjenta, may increase the risk of pancreatitis and pancreatic cancer.

2014

The manufacturer settled more than 4,000 lawsuits in May 2014 for $650 million.

2016

Then, the company sold the United States rights to Sanofi in 2016.

2017

She joined Drugwatch in 2017.

2018

In 2018, the FDA warned that SGLT2 inhibitors including Jardiance, Invokana and Farxiga may contribute to a rare, life-threatening genital infection called Fournier’s gangrene.

2019

Zimmerman, K. (2019, September 16). Boehringer Ingelheim, Sanofi targeted in class-action suit over Zantac.

In 2019’s fifth edition of The Corporate Reputation of Pharma – from the Perspective of Respiratory-Conditions Patient Groups, Boehringer ranked first out of 13 companies for corporate reputation.

Boehringer did 74 percent of its business in human medicines, 21 percent on animal health and the rest on biopharmaceuticals in 2019.

The drugmaker’s top selling drugs in 2019 made billions worldwide in the areas of human pharmaceuticals and animal health.

2020

Reuters. (2020, November 10). Boehringer to settle thousands of cases over Pradaxa blood thinner bleeding risk.

In response to the COVID-19 pandemic, Boehringer stepped up its research and development efforts to study new treatments and repurpose existing products to fight the virus in 2020.

Boehringer Ingelheim. (2020). Retrieved from https://www.boehringer-ingelheim.com/press-release/fight-against-covid-19-pandemic-shapes-global-business-activities

2021

17, 2021, more than 560 federal Zantac lawsuits have been consolidated in Florida federal court and lawyers expect many more to be filed.

© 2021 Drugwatch.com Privacy Policy / Do Not Sell My Info

Founded
1984
Company Founded
Headquarters
Ridgefield, CT
Company Headquarter
Founders
Albert Boehringer
Company Founders

Boehringer Ingelheim Jobs Nearby

Boehringer Ingelheim Jobs

Boehringer Ingelheim Similar Companies

Company NameFounded DateRevenueEmployee SizeJob Openings
Hi-Tech Pharmacal1982
1982$232.4M200-
Alvogen2008
2008$1.1B2,800-
Novartis1996
1996$49.9B110,0002,013
AstraZeneca1997
1997$25.9B76,100861
Eli Lilly and Company1876
1876$22.3B33,625681
Merial1981
1981$2.9B6,900-
Merck1891
1891$46.8B74,0005,784
Bristol-Myers Squibb1887
1887$26.1B30,0003,752
Janssen1979
1979$601.4M1,500-
PDI,1987
1987$22.0M350-
Find Jobs from Similar Companies
Personalize your job search. Where would you like to work?
0 selections

Boehringer Ingelheim Similar Companies Jobs